Conservative Treatment of Esotropia in Children up to 3 Years Old
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02404324|
Recruitment Status : Unknown
Verified March 2015 by National Centre of Ophthalmology named after academician Zarifa Aliyeva.
Recruitment status was: Active, not recruiting
First Posted : March 31, 2015
Last Update Posted : April 11, 2017
|Condition or disease||Intervention/treatment||Phase|
|Esotropia||Other: Prescription of spectacles||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prescription of Full Optical Correction in Refractive Errors to Treat Esotropia in Children up to 3 Years Old|
|Study Start Date :||January 2012|
|Estimated Primary Completion Date :||October 2017|
|Estimated Study Completion Date :||November 2017|
Esotropia is treated by full optical correction (spectacles prescription) in all children with refractive errors. Special attention is paid to astigmatism up to 0.5 Dptr.
Intervention: Prescription of spectacles
Other: Prescription of spectacles
All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dptr to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization are administered to the children.
- The angle of deviation [ Time Frame: 2 years ]The absolute success is defined as restored symmetrical eye position.Qualified success is considered as reduction of the angle of deviation. Patients are examined 24 months later to assess outcome of treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02404324
|Study Director:||Elmar Kasimov, Professor||National Centre of Ophthalmology named after academician Zarifa Aliyeva|